C
29.04
0.66 (2.33%)
| Previous Close | 28.38 |
| Open | 28.42 |
| Volume | 8,171,001 |
| Avg. Volume (3M) | 15,080,706 |
| Market Cap | 14,262,502,400 |
| Price / Earnings (TTM) | 7.05 |
| Price / Earnings (Forward) | 9.37 |
| Price / Sales | 0.090 |
| Price / Book | 0.600 |
| 52 Weeks Range | |
| Earnings Date | 24 Oct 2025 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Bearish | Bearish |
| Healthcare Plans (Global) | Bearish | Bearish | |
| Stock | Centene Corporation | Bearish | Bearish |
AIStockmoo Score
1.1
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.13 |
|
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Value |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Jun 2025 | 8,043,255 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 43.00 (Oppenheimer, 48.07%) | Buy |
| Median | 33.00 (13.64%) | |
| Low | 28.00 (Baird, -3.58%) | Hold |
| 28.00 (Morgan Stanley, -3.58%) | Hold | |
| Average | 33.92 (16.80%) | |
| Total | 3 Buy, 9 Hold, 1 Sell | |
| Avg. Price @ Call | 28.98 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 12 Sep 2025 | 35.00 (20.52%) | Hold | 33.26 |
| 04 Sep 2025 | 33.00 (13.64%) | Hold | 28.65 | |
| Truist Securities | 12 Sep 2025 | 39.00 (34.30%) | Buy | 33.26 |
| 28 Jul 2025 | 35.00 (20.52%) | Buy | 26.86 | |
| Bernstein | 05 Sep 2025 | 36.00 (23.97%) | Buy | 28.98 |
| Cantor Fitzgerald | 26 Aug 2025 | 38.00 (30.85%) | Hold | 28.66 |
| 28 Jul 2025 | 38.00 (30.85%) | Hold | 26.86 | |
| Morgan Stanley | 04 Aug 2025 | 28.00 (-3.58%) | Hold | 26.21 |
| 10 Jul 2025 | 33.00 (13.64%) | Hold | 32.52 | |
| JP Morgan | 29 Jul 2025 | 30.00 (3.31%) | Hold | 25.53 |
| 02 Jul 2025 | 48.00 (65.29%) | Hold | 33.78 | |
| Oppenheimer | 28 Jul 2025 | 43.00 (48.07%) | Buy | 26.86 |
| 15 Jul 2025 | 51.00 (75.62%) | Buy | 30.00 | |
| UBS | 28 Jul 2025 | 31.00 (6.75%) | Hold | 26.86 |
| 02 Jul 2025 | 45.00 (54.96%) | Hold | 33.78 | |
| Baird | 25 Jul 2025 | 28.00 (-3.58%) | Hold | 28.39 |
| Wells Fargo | 23 Jul 2025 | 30.00 (3.31%) | Hold | 29.42 |
| TD Cowen | 21 Jul 2025 | 33.00 (13.64%) | Hold | 27.43 |
| B of A Securities | 16 Jul 2025 | 30.00 (3.31%) | Sell | 30.41 |
| 02 Jul 2025 | 52.00 (79.06%) | Hold | 33.78 | |
| Mizuho | 11 Jul 2025 | 40.00 (37.74%) | Hold | 31.44 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |